メニューにジャンプ コンテンツにジャンプ
Disease Control and Prevention Center

Top > Publication list by year > Publications (2014)

Publications (2014)

Publication (International journal)

  1. Binh NG, Hayakawa K, Co DX, Tuan ND, Anh NH, Thuy NT, Phuong DM, Huong NT, Thuy PT, Chau NQ, Nhung PH, Gam DT, Hai DT, Huong TT, Van Anh L, Takeshita N, Ohmagari N.
    The efficacy and nephrotoxicity associated with colistin use in an intensive care unit in Vietnam: Use of colistin in a population of lower body weight.
    Int J Infect Dis. 2015 Mar 30. pii: S1201-9712(15)00081-8. doi: 10.1016/j.ijid.2015.03.020. [Epub ahead of print]
  2. Sherchan JB, Hayakawa K, Miyoshi-Akiyama T, Ohmagari N, Kirikae T, Nagamatsu M, Tojo M, Ohara H, Sherchand JB, Tandukar S.
    Clinical epidemiology and molecular analysis of extended-spectrum β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types ST131 and ST648.
    Antimicrob Agents Chemother. 2015 Mar 30. pii: AAC.00270-15. [Epub ahead of print]
  3. Kutsuna S, Kawabata H, Ohmagari N.
    Imported lyme disease. Intern Med. 2015;54(6):691. doi: 10.2169/internalmedicine.54.3700. Epub 2015 Jan 15.
  4. Khan A, Rao A, Reyes-Sacin C, Hayakawa K, Szpunar S, Riederer K, Kaye K, Fishbain JT, Levine D.
    Use of portable electronic devices in a hospital setting and their potential for bacterial colonization.
    Am J Infect Control. 2015 Mar 1;43(3):286-8. doi: 10.1016/j.ajic.2014.11.013. Epub 2015 Jan 1.
  5. Kawamura I, Ohmagari N, Tsukahara M, Kudo T, Kurai H.
    Surveillance of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a comprehensive cancer center in Japan, 2009-2013.
    Am J Infect Control. 2015 Feb;43(2):185-7. doi: 10.1016/j.ajic.2014.11.005. Epub 2014 Dec 17.
  6. Brett-Major DM, Jacob ST, Jacquerioz FA, Risi GF, Fischer WA 2nd, Kato Y, Houlihan CF, Crozier I, Bosa HK, Lawler JV, Adachi T, Hurley SK, Berry LE, Carlson JC, Button TC, McLellan SL, Shea BJ, Kuniyoshi GG, Ferri M, Murthy SG, Petrosillo N, Lamontagne F, Porembka DT, Schieffelin JS, Rubinson L, O’Dempsey T, Donovan SM, Bausch DG, Fowler RA, Fletcher TE.
    Being ready to treat ebola virus disease patients.
    Am J Trop Med Hyg. 2015 Feb;92(2):233-7. doi: 10.4269/ajtmh.14-0746. Epub 2014 Dec 15. PubMed Central PMCID: PMC4347319.
  7. Shimizu S, Kikuchi T, Koga M, Kato Y, Matsuoka H, Maruyama H, Kimura M; for the Research Group on Chemotherapy of Tropical Diseases.
    Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers ? A retrospective analysis.
    Travel Med Infect Dis. 2014 Nov 20. pii: S1477-8939(14)00219-1. doi: 10.1016/j.tmaid.2014.11.005. [Epub ahead of print]
  8. Tanizaki R, Kato Y, Iwagami M, Kutsuna S, Ujiie M, Takeshita N, Hayakawa K, Kanagawa S, Kano S, Ohmagari N.
    Performance of Rapid Diagnostic Tests for Plasmodium ovale Malaria in Japanese Travellers.
    Trop Med Health. 2014 Dec;42(4):149-53. doi: 10.2149/tmh.2014-07. Epub 2014 Sep 3. PubMed Central PMCID: PMC4229013.
  9. Kutsuna S, Kato Y, Koizumi N, Yamamoto K, Fujiya Y, Mawatari M, Takeshita N, Hayakawa K, Kanagawa S, Ohmagari N.
    Travel-related leptospirosis in Japan: a report on a series of five imported cases diagnosed at the National Center for Global Health and Medicine.
    J Infect Chemother. 2015 Mar;21(3):218-23. doi: 10.1016/j.jiac.2014.10.004. Epub 2014 Nov 6.
  10. Tojo M, Mawatari M, Hayakawa K, Nagamatsu M, Shimada K, Mezaki K, Sugiki Y, Kuroda E, Takeshita N, Kutsuna S, Fujiya Y, Miyoshi-Akiyama T, Kirikae T, Ohmagari N.
    Multidrug-resistant Acinetobactor baumannii isolated from a traveler returned from Brunei.
    J Infect Chemother. 2015 Mar;21(3):212-4. doi: 10.1016/j.jiac.2014.08.029. Epub 2014 Oct 23.
  11. Yamamoto K, Hayakawa K, Ohmagari N.
    Daptomycin-induced pneumonitis in a patient with chronic obstructive pulmonary disease (COPD).
    Intern Med. 2014;53(21):2559-60. Epub 2014 Nov 1.
  12. Tojo M, Nagamatsu M, Hayakawa K, Mezaki K, Kirikae T, Ohmagari N.
    Evaluation of an automated rapid diagnostic test for detection of Clostridium difficile.
    PLoS One. 2014 Aug 29;9(8):e106102. doi: 10.1371/journal.pone.0106102. eCollection 2014. PubMed Central PMCID: PMC4149505.
  13. Kutsuna S, Ohmagari N.
    Dengue fever.
    Intern Med. 2014;53(15):1727. Epub 2014 Aug 1.
  14. Kobayashi T, Hayakawa K, Mawatari M, Mezaki K, Takeshita N, Kutsuna S, Fujiya Y, Kanagawa S, Ohmagari N, Kato Y, Morita M.
    Case report: failure under azithromycin treatment in a case of bacteremia due to Salmonella enterica Paratyphi A.
    BMC Infect Dis. 2014 Jul 20;14:404. doi: 10.1186/1471-2334-14-404. PubMed Central PMCID: PMC4223471.
  15. Ohmagari N, Kurai H, Yamagishi Y, Mikamo H.
    Are strict isolation policies based on susceptibility testing actually effective in the prevention of the nosocomial spread of multi-drug-resistant gram-negative rods?
    Am J Infect Control. 2014 Jul;42(7):739-43. doi: 10.1016/j.ajic.2014.04.003.
  16. Sakamoto N, Maeda T, Mikita K, Kato Y, Yanagisawa N, Suganuma A, Imamura A, Nakamura-Uchiyama F, Miyahira Y, Kawana A, Ohnishi K, Ajisawa A.
    Clinical presentation and diagnosis of toxoplasmic encephalitis in Japan.
    Parasitol Int. 2014 Oct;63(5):701-4. doi: 10.1016/j.parint.2014.05.007. Epub 2014 Jun 11.
  17. Tojo M, Tada T, Shimojima M, Tanaka M, Narahara K, Miyoshi-Akiyama T, Kirikae T, Ohmagari N.
    Dissemination in Japan of multidrug-resistant Pseudomonas aeruginosa isolates producing IMP-type metallo-β-lactamases and AAC(6′)-Iae/AAC(6′)-Ib.
    J Infect Chemother. 2014 Sep;20(9):586-8. doi: 10.1016/j.jiac.2014.04.014. Epub 2014 Jun 6.
  18. Hayakawa K, Miyoshi-Akiyama T, Kirikae T, Nagamatsu M, Shimada K, Mezaki K, Sugiki Y, Kuroda E, Kubota S, Takeshita N, Kutsuna S, Tojo M, Ohmagari N.
    Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
    Antimicrob Agents Chemother. 2014 Jun;58(6):3441-50. doi: 10.1128/AAC.02652-13. Epub 2014 Apr 7. PubMed Central PMCID: PMC4068452.
  19. Tojo M, Fujita T, Ainoda Y, Nagamatsu M, Hayakawa K, Mezaki K, Sakurai A, Masui Y, Yazaki H, Takahashi H, Miyoshi-Akiyama T, Totsuka K, Kirikae T, Ohmagari N.
    Evaluation of an automated rapid diagnostic assay for detection of Gram-negative bacteria and their drug-resistance genes in positive blood cultures.
    PLoS One. 2014 Apr 4;9(4):e94064. doi: 10.1371/journal.pone.0094064. eCollection 2014. PubMed Central PMCID: PMC3976387.
  20. Uemura H, Hayakawa K, Shimada K, Tojo M, Nagamatsu M, Miyoshi-Akiyama T, Tamura S, Mesaki K, Yamamoto K, Yanagawa Y, Sugihara J, Kutsuna S, Takeshita N, Shoda N, Hagiwara A, Kirikae T, Ohmagari N.
    Parvimonas micra as a causative organism of spondylodiscitis: a report of two cases and a literature review.
    Int J Infect Dis. 2014 Jun;23:53-5. doi: 10.1016/j.ijid.2014.02.007. Epub 2014 Mar 26. Review.
  21. Kutsuna S, Kato Y, Takasaki T, Moi M, Kotaki A, Uemura H, Matono T, Fujiya Y, Mawatari M, Takeshita N, Hayakawa K, Kanagawa S, Ohmagari N.
    Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014 [corrected].
    Euro Surveill. 2014 Jan 30;19(4). pii: 20683. Erratum in: Euro Surveill. 2014;19(5):20694.
  22. Okada K, Kimura T, Mikamo H, Kasahara K, Seki M, Takakura S, Tokimatsu I, Ohmagari N, Takahashi Y, Matsumoto K, Igarashi M, Kobayashi M, Hamada Y, Mochizuki T, Kimura M, Nishi Y, Tanigawara Y, Takesue Y; Japanese Society of Chemotherapy; Japanese Society of Therapeutic Drug Monitoring.
    Clinical practice guidelines for therapeutic drug monitoring of arbekacin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
    J Infect Chemother. 2014 Jan;20(1):1-5. doi: 10.1016/j.jiac.2013.08.008. Epub 2013 Dec 11.
  23. Takeshita N, Lim CK, Mizuno Y, Shimbo T, Kotaki A, Ujiie M, Hayakawa K, Kato Y, Kanagawa S, Kaku M, Takasaki T.
    Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults.
    J Infect Chemother. 2014 Apr;20(4):238-42. doi: 10.1016/j.jiac.2013.11.010. Epub 2014 Jan 29.
  24. Fujita T, Endo M, Gu Y, Sato T, Ohmagari N.
    Mycobacterium tuberculosis infection in cancer patients at a tertiary care cancer center in Japan.
    J Infect Chemother. 2014 Mar;20(3):213-6. doi: 10.1016/j.jiac.2013.11.005. Epub 2014 Jan 22.
  25. Mizuno Y, Yamamoto A, Komiya T, Takeshita N, Takahashi M.
    Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.
    J Infect Chemother. 2014 Jan;20(1):35-7. doi: 10.1016/j.jiac.2013.11.003. Epub 2013 Dec 11.
  26. Kutsuna S, Hayakawa K, Ohmagari N.
    Scarlet fever in an adult.
    Intern Med. 2014;53(2):167-8. Epub 2012 Mar 1.
  27. Kutsuna S, Hayakawa K, Kato Y, Fujiya Y, Mawatari M, Takeshita N, Kanagawa S, Ohmagari N.
    The usefulness of serum C-reactive protein and total bilirubin levels for distinguishing between dengue fever and malaria in returned travelers.
    Am J Trop Med Hyg. 2014 Mar;90(3):444-8. doi: 10.4269/ajtmh.13-0536. Epub 2014 Jan 13. PubMed Central PMCID: PMC3945689.
  28. Kutsuna S, Ohmagari N, Tanizaki R, Hagino N, Nishikomori R, Ujiie M, Takeshita N, Hayakawa K, Kato Y, Kanagawa S.
    The first case of adult-onset PFAPA syndrome in Japan.
    Mod Rheumatol. 2013 Dec 2. [Epub ahead of print]
  29. Mawatari M, Kato Y, Hayakawa K, Morita M, Yamada K, Mezaki K, Kobayashi T, Fujiya Y, Kutsuna S, Takeshita N, Kanagawa S, Ohnishi M, Izumiya H, Ohmagari N.
    Salmonella enterica serotype Paratyphi A carrying CTX-M-15 type extended-spectrum beta-lactamase isolated from a Japanese traveller returning from India, Japan, July 2013.
    Euro Surveill. 2013 Nov 14;18(46). pii: 20632.
  30. Yamamoto K, Kato Y, Shindo T, Ujiie M, Takeshita N, Kanagawa S, Kunimatsu J, Tamori Y, Kano T, Okuno R, Takahashi H, Ohmagari N.
    Meningococcemia due to the 2000 Hajj-associated outbreak strain (Serogroup W-135 ST-11) with immunoreactive complications.
    Jpn J Infect Dis. 2013;66(5):443-5.
  31. Kutsuna S, Kawabata H, Kasahara K, Takano A, Mikasa K.
    The first case of imported relapsing fever in Japan.
    Am J Trop Med Hyg. 2013 Sep;89(3):460-1. doi: 10.4269/ajtmh.13-0187. Epub 2013 Jul 15. PubMed Central PMCID: PMC3771281.
  32. Tanizaki R, Ujiie M, Kato Y, Iwagami M, Hashimoto A, Kutsuna S, Takeshita N, Hayakawa K, Kanagawa S, Kano S, Ohmagari N.
    First case of Plasmodium knowlesi infection in a Japanese traveller returning from Malaysia.
    Malar J. 2013 Apr 15;12:128. doi: 10.1186/1475-2875-12-128. PubMed Central PMCID: PMC3637542.
  33. Kobayashi T, Kato Y, Yamauchi Y, Ujiie M, Takeshita N, Mizuno Y, Kanagawa S, Kano S, Ohmagari N.
    [Clinical experience of primaquine use for treatment of vivax and ovale malaria in Japanese travelers].
    Kansenshogaku Zasshi. 2013 Jan;87(1):22-6. Japanese.
  34. Ohmagari N, Sakurai S, Taniguchi K, Fujikura Y, Atarashi K.
    [Discussion meeting on the effect of social event over the practice of infectious diseases].
    Nihon Naika Gakkai Zasshi. 2012 Nov 10;101(11):3201-17. Japanese.
  35. Kato Y, Kano S, Ohnishi K.
    [Infectious diseases: progress in diagnosis and treatment. Topics: III. Emerging and re-emerging infectious diseases; 4. Emerging parasitic diseases].
    Nihon Naika Gakkai Zasshi. 2012 Nov 10;101(11):3162-7. Japanese.
  36. Hamada Y, Watanabe K, Tada T, Mezaki K, Takeuchi S, Shimizu T, Kirikae T, Ohmagari N.
    Three cases of IMP-type metallo-β-lactamase-producing Enterobacter cloacae bloodstream infection in Japan. J Infect Chemother. 2013 Oct;19(5):956-8. doi: 10.1007/s10156-012-0520-6. Epub 2012 Nov 19.
    Erratum in: J Infect Chemother. 2013 Oct;19(5):959. Tatsuya, Tada [corrected to Tada, Tatsuya].
  37. Fukushi M, Yamashita M, Miyoshi-Akiyama T, Kubo S, Yamamoto K, Kudo K.
    Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.
    PLoS One. 2012;7(8):e42419. doi: 10.1371/journal.pone.0042419. Epub 2012 Aug 1. PubMed Central PMCID: PMC3409853.
  38. Manabe T, Higuera Iglesias AL, Vazquez Manriquez ME, Martinez Valadez EL, Ramos LA, Izumi S, Takasaki J, Kudo K.
    Socioeconomic factors influencing hospitalized patients with pneumonia due to influenza A(H1N1)pdm09 in Mexico.
    PLoS One. 2012;7(7):e40529. doi: 10.1371/journal.pone.0040529. Epub 2012 Jul 11. PubMed Central PMCID: PMC3394736.
  39. Ujiie M, Moi ML, Kobayashi T, Takeshita N, Kato Y, Takasaki T, Kanagawa S.
    Dengue virus type-3 infection in a traveler returning from Benin to Japan.
    J Travel Med. 2012 Jul;19(4):255-7. doi: 10.1111/j.1708-8305.2012.00617.x.
  40. Ohmagari N.
    [Antimicrobial stewardship].
    Nihon Rinsho. 2012 Feb;70(2):298-304. Japanese.
  41. Ohmagari N.
    [Infection prevention strategy for antimicrobial-resistant organisms].
    Gan To Kagaku Ryoho. 2012 Feb;39(2):162-4. Japanese.
  42. Yamamoto K, Kato Y, Shindo T, Ujiie M, Takeshita N, Kanagawa S.
    Gingivostomatitis with fever and rash. Measles.
    Clin Infect Dis. 2012 Feb 1;54(3):392, 443-4. doi: 10.1093/cid/cir739.
  43. Ujiie M, Moi ML, Takeda N.
    Dengue maculopathy in a traveler.
    Am J Trop Med Hyg. 2011 Dec;85(6):965-6. doi: 10.4269/ajtmh.2011.11-0120. PubMed Central PMCID: PMC3225171.
  44. Manabe T, Pham TP, Vu VC, Takasaki J, Dinh TT, Nguyen TM, Shimbo T, Bui TT, Izumi S, Tran TH, Ngo QC, Kudo K.
    Impact of educational intervention concerning awareness and behaviors relating to avian influenza (H5N1) in a high-risk population in Vietnam.
    PLoS One. 2011;6(8):e23711. doi: 10.1371/journal.pone.0023711. Epub 2011 Aug 22. PubMed Central PMCID: PMC3161759.
  45. Fukushi M, Ito T, Oka T, Kitazawa T, Miyoshi-Akiyama T, Kirikae T, Yamashita M, Kudo K.
    Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain.
    PLoS One. 2011;6(6):e21207. doi: 10.1371/journal.pone.0021207. Epub 2011 Jun 20. PubMed Central PMCID: PMC3118813.
  46. Mizuno Y, Kato Y, Takeshita N, Ujiie M, Kobayashi T, Kanagawa S, Kudo K, Lim CK, Takasaki T.
    Clinical and radiological features of imported chikungunya fever in Japan: a study of six cases at the National Center for Global Health and Medicine.
    J Infect Chemother. 2011 Jun;17(3):419-23. doi: 10.1007/s10156-010-0124-y. Epub 2010 Sep 23.
  47. Kudo K, Manabe T.
    [Clinical and sociological prospectives on pandemic (H1N1) 2009].
    Uirusu. 2010 Jun;60(1):9-15. Review. Japanese.
  48. Kato Y.
    [Pneumonia and acute respiratory distress syndrome due to pandemic influenza H1N1 2009].
    Nihon Rinsho. 2010 Sep;68(9):1666-70. Review. Japanese.

Presentations at International Conferences and Forums

  1. Fujiya Y, Hayakawa K, Yamamoto K, Mawatari M, Kutsuna S, Takeshita N, Kato Y, Shuzo K, Omagari N.
    Clinical characteristics of invasive Group G Streptococcal diseases in a tertiary care hospital in Japan : Comparison with invasive non-Group G streptococcal diseases.
    Presented as a poster presentation at ID week, Philadelphia, Oct, 2014.
  2. Hayakawa K, Sherchan JB, Kirikae T, Nagamatsu M, Tojo M, Miyoshi-Akiyama T, Ohara H, Sherchand JB, Tandukar S, Ohmagari N.
    Differences in the clinical and microbiological characteristics of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli between Japan and Nepal.
    Poster presentation at Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC, Sep, 2014.
  3. Sherchan JB, Hayakawa K, Ohmagari N, Kirikae T, Nagamatsu M, Tojo M, Miyoshi-Akiyama T, Ohara H, Sherchand JB, Tandukar S.
    Epidemiology of Extended-spectrum β-Lactamase (ESBL)-producing Escherichia coli in Nepal: Predominance of CTX-M-15-type ESBL.
    Poster presentation at Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC, Sep, 2014.
  4. Yamamoto K, Hayakawa K, Kutsuna S, Takeshita N, Kato Y, Kanagawa S, Yamada K, Mezaki K, Kirikae T, Ohmagari N.
    Comparison of the clinical and microbiological characteristics of Campylobacter and Helicobacter bacteraemia: the importance of time to blood culture positivity.
    Poster presentation at European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, May, 2014.
  5. Hayakawa K, Miyoshi-Akiyama T, Kubota S, Kuroda E, Sugiki Y, Nagamatsu M, Takeshita N, Kutsuna S, Kirikae T, Ohmagari N.
    Epidemiology and predictors of IMP-type metallo-betalactamase-producing Enterobacter cloacae isolation in a tertiary medical centre: a case-control study.
    Poster presentation at European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, May, 2014.
  6. Sugiki Y, Ohmagari N, Mawatari M, Kuroda E, Kubota S, Takeshita N, Kutsuna S, Fujiya Y, Mezaki K, Hayakawa K.
    Epidemiology and trends in MRSA infections at a large tertiary hospital in Japan: The importance of a ward-based continuous infection control effort.
    Poster presentation at SHEA Spring 2014 Conference, Denver, April, 2014.
  7. Pogue JM, Marchaim D, Hayakawa K, Pulluru H, Kaye KS.
     Colistin-associated nephrotoxicity: the impact of definition.
    Presented as an oral presentation at European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, May, 2014.
  8. Dhar S, Martin EM, McRoberts JP, Hayakawa K, Lazarovitch T, Zaidenstein R, Perez F, Bonomo RA, Kaye KS, Marchaim D.
    The epidemiology of carbapenem-resistant Klebsiella pneumoniae stratified by multi-locus sequence typing.
    Presented as a poster presentation at European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, May, 2014.

Publication list by year

Publications (2021)
Publications (2020)
Publications (2019)
Publications (2018)
Publications (2017)
Publications (2016)
Publications (2015)
Publications (2014)
Publications (2013)
Publications (2012)
Publications (2011)
Publications (2010)

Copyright (C) National Center for Global Health and Medicine,Disease Control and Prevention Center All rights reserved.